Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
17.28
+0.31 (1.83%)
Jun 3, 2025, 2:45 PM CST
SHE:002755 Revenue
Beijing Aosaikang Pharmaceutical had revenue of 508.56M CNY in the quarter ending March 31, 2025, with 13.39% growth. This brings the company's revenue in the last twelve months to 1.84B, up 18.30% year-over-year. In the year 2024, Beijing Aosaikang Pharmaceutical had annual revenue of 1.78B with 23.15% growth.
Revenue (ttm)
1.84B
Revenue Growth
+18.30%
P/S Ratio
8.71
Revenue / Employee
1.86M
Employees
988
Market Cap
16.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.78B | 334.18M | 23.15% |
Dec 31, 2023 | 1.44B | -429.11M | -22.92% |
Jan 1, 2023 | 1.87B | -1.23B | -39.72% |
Jan 1, 2022 | 3.11B | -676.02M | -17.87% |
Dec 31, 2020 | 3.78B | -735.94M | -16.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |